Dual Blockade of EGFR and C-Met Abrogates Redundant Signaling and Proliferation in Head and Neck Carcinoma Cells
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-10-3339
Full Text
Open PDFAbstract
Available in full text
Date
May 27, 2011
Authors
Publisher
American Association for Cancer Research (AACR)